ChiCTR2000030261
A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19)
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Unclear
References (2)
Sur 2021
Exosomes from COVID-19 patients carry tenascin-C and fibrinogen-β in triggering inflammatory signals in cells of distant organ
  1. Study Type
  2. Observational
  1. Study Aim
  2. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
NCT05191381
Immune Modulation by Stem Cell Derived Exosomes in Critically Ill COVID-19
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
Malekpour 2021b
Exosomes derived from adipose tissue mesenchymal stem cells decrease TH-17 frequency in COVID-19 patients
  1. Study Type
  2. Observational
  1. Study Aim
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Not Applicable
References (1)
NCT04747574
A Phase I Feasibility Study to Evaluate the Safety of CD24-Exosomes in Patients With Moderate/Severe COVID-19 Infection
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Single Arm/Controlled Before After
  1. Intervention Assignment
  2. Not Applicable
References (1)
Song 2020k
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
NCT04602442
The Extended Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Two-Sided Pneumonia
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Other
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
References (1)
NCT04491240
THE PROTOCOL OF EVALUATION OF SAFETY AND EFFICIENCY OF METHOD OF EXOSOME INHALATION IN SARS-CoV-2 ASSOCIATED TWO-SIDED PNEUMONIA
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Other
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
References (1)
Patel 2022av
Successful Treatment of COVID-19 Patient on ECMO Using Mesenchymal Stromal Cells (MSC)-Derived Exosomes: a Case Report
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Treatment and Management
  1. Study Design
  2. Case Report
  1. Intervention Assignment
  2. Not Applicable
References (1)
Wu 2021ae
A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood
  1. Study Type
  2. Observational
  1. Study Aim
  2. Diagnostic/Prognostic
  3. Mechanism
  1. Study Design
  2. Case series/Case control/Cohort
  1. Intervention Assignment
  2. Not Applicable
References (1)
IRCT20130812014333N164
Investigation of the effects of the exosomes on patients with COVID-19
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
References (1)
IRCT20200413047063N2
Exosomes Derived from placental Mesenchymal Stem Cells as Treatment for Severe COVID-19: phase 1 & 2 Clinical Trials
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
References (1)
Sengupta 2020
Exosomes Derived From Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Single Arm/Controlled Before After
  1. Intervention Assignment
  2. Not Applicable
References (3)
0 Selected
ExportClear